Navigation Links
Elsevier Integrates its Clinical Decision Support Solutions Into PatientKeeper CPOE
Date:2/21/2012

PHILADELPHIA, Pennsylvania and WALTHAM, Massachusetts, February 21, 2012 /PRNewswire/ --

New collaboration delivers Elsevier's evidence-based clinical decision support content and analytics tools into the physician workflow through PatientKeeper CPOE™

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and PatientKeeper®, the leading provider of physician healthcare information systems, today announced a collaboration in which Elsevier will integrate its clinical decision support (CDS) and analytics resources into PatientKeeper's CPOE software product. The collaboration brings world-class, evidence-based clinical content into the physician's workflow through PatientKeeper's uniquely physician-friendly computerized physician order entry (CPOE) system.

For PatientKeeper's physician users, this collaboration provides value-added content that enables physicians to make better and faster patient care decisions that lead to improved outcomes. The collaboration delivers deeper integration with "context specific" CDS information from many of Elsevier's solutions, including Gold Standard's Clinical Pharmacology and integrated Drug Database, the Pinpoint clinical analytics suite from MEDai, and Elsevier's Order Sets solution, which will launch later in 2012. In addition, Elsevier will provide PatientKeeper access to Elsevier's CPM interdisciplinary, evidence-based clinical practice guidelines, and Elsevier's ClinicalKey, a new clinical insight engine which rapidly helps physicians find the most relevant information to answer complex clinical questions.

"PatientKeeper's CPOE product combined with Elsevier's clinical content and analytics offers a powerful combination for physicians who increasingly seek more robust clinical decision support tools to fit seamlessly into their existing workflow," said Jay Katzen, Managing Director of CDS at Elsevier. "This is another example of how Elsevier is integrating its content and other resources with industry leading vendors like PatientKeeper to make healthcare more efficient and to improve outcomes overall."

PatientKeeper CPOE and all of the PatientKeeper applications were designed to fit seamlessly into a physician's existing workflow, so it is quickly and easily adopted by physicians. Physicians are able to accomplish all of the things they normally do throughout the day - pre-rounding, ordering, documenting, signing-out, charging, etc. - using a single, fully integrated system. PatientKeeper sits on top of the existing information systems in a healthcare community to provide physicians with a comprehensive view of all the clinical data on all their patients. Currently, more than 70 hospitals and health systems across the United States and Canada have purchased PatientKeeper CPOE to streamline the ordering process for physicians and drive meaningful physician use of a critical healthcare information technology.

"We specialize in making sure that our software enables physicians to deliver better care, by providing them with technology that matches the way they practice and most importantly, software that saves them time and helps them practice more effectively," said Paul Brient, President and CEO of PatientKeeper. "Our physician users count on us to give them the fastest and easiest way to pull actionable content into their workflow through PatientKeeper CPOE. The historical approach to CPOE and Clinical Decision Support often inundates physicians with a high percentage of irrelevant or non-actionable alerts. We're delighted to collaborate with Elsevier, whose content is unmatched and who shares our goal of creating a streamlined, physician friendly environment."

Under ARRA and the HITECH Act, hospitals and physicians are required to achieve high levels of physician adoption of technology including CPOE. PatientKeeper and Elsevier believe that collaborating to provide additional content and tools within PatientKeeper's physician-friendly CPOE application will lead to high levels of sustained adoption and, most importantly, a happy, more effective physician community.

To learn more about Elsevier's complete suite of CDS solutions, visit http://www.clinicaldecisionsupport.com. For more information on PatientKeeper CPOE and their physician workflow solutions, visit http://www.patientkeeper.com.

About PatientKeeper

PatientKeeper® Inc., the leading provider of physician healthcare information systems, enables physicians and hospitals to focus on their patients, not technology. PatientKeeper provides highly intuitive software for physicians that streamlines workflow to improve productivity and patient care. PatientKeeper's CPOE, physician documentation, electronic charge capture and other applications run on desktop and laptop computers and popular handheld devices and tablets. PatientKeeper's software integrates with existing healthcare information systems to create the most effective solution for driving physician adoption of technology, meeting Meaningful Use and transitioning to ICD-10. For more information about PatientKeeper, which is headquartered near Boston, Mass., visit http://www.patientkeeper.com or call +1-781-373-6100.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contacts
Christopher Capot
KNB Communications
+1-203-379-8019
ccapot@knbpr.com

David Domeshek
Public Relations Manager
+1-781-373-6232
ddomeshek@patientkeeper.com



'/>"/>
SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elsevier Introduces Expert Discovery Application for SciVerse Hub
2. Elsevier Honored With Six PROSE Awards
3. Elsevier and OpenHelix Release Tutorial Suites for SciVerse Applications
4. Elsevier and Leidens Scaliger Institute Establish Fellowship Program for Rare Books Scholars
5. Elsevier Announces Two Tetrahedron Symposia for 2012
6. New Stage of Scientific Development for St.Petersburg State University Marked by Signed Agreement With Elsevier
7. Elsevier and the Fulbright Commission Honor UK Research Talent With the UK Scopus Young Researcher Award
8. Elseviers BrainNavigator 3.2 Offers New Functionality to Speed Neurological Research
9. Elsevier Announces New 2012 Frontlist eBooks Collection on SciVerse ScienceDirect Available for Advance Purchase
10. West Kentucky Community and Technical College Embraces Elseviers Digital Textbook Platform for Radiography Program
11. Elsevier Honors the 2011 Nobel Laureates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... PHILADELPHIA , Jan. 18, 2017 The Philadelphia ... three companies developing medical devices for children. The Consortium ... to receive seed grants of $50,000 each. The ... amplifies weak nerve signals, a hand-operated rapid blood delivery system ... ears in babies. ...
(Date:1/18/2017)... , Jan. 18, 2017   Regenicin, Inc. ... biotechnology company specializing in the development and commercialization of ... tissues and organs, recently reported the Company,s operating results ... 2017. As the Company described in its ... a year of substantial accomplishments. The Company,s contract laboratory ...
(Date:1/18/2017)... 2017  Dermata Therapeutics, LLC, a biotechnology company ... variety of dermatological diseases, announces dosing the first ... Phase 2 acne rosacea study. DMT210 is a ... cytokines in the skin responsible for the inflammation ... This clinical trial, DMT210-003, is a 12-week, ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... 2017 , ... Connecticut Dermatology Group (CDG) is proud and excited to welcome ... Dr. Kim brings an extensive background in cutting-edge dermatology care and research to ... welcome back Dr. Kim to the CDG team” said President and Managing Partner Dr. ...
(Date:1/19/2017)... ... , ... Sales Focus Inc. (SFI), a Maryland-based sales outsourcing company, announced today ... past 20 years SFI has been recognized as the world’s leader in Intelligent Sales ... the US market. The new clients include: Panacea Pro, Campseekers, Contentmart, Stress Pal, ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Infinity® Massage Chairs ... plan and implement new sales and marketing strategies. Grover comes with a total of ... 5 and a half years as Executive Vice President of Direct Sales at Traeger® ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... of Proctology) announced today the opening of 3 medical offices specializing specifically ... Hemorrhoids Center of Los Angeles (Beverly Hills), Hemorrhoids Center of Newport Beach, ...
(Date:1/18/2017)... ... 18, 2017 , ... A recent video posting of a new fidget product ... of fidgeting to relieve stress and anxiety. No one was more surprised than ... had just completed a successful Kickstarter campaign raising $67,000 on the popular crowdfunding platform. ...
Breaking Medicine News(10 mins):